Abstract

Reducing unnecessary antibiotic use, particularly among children, continues to be a public health priority. Previous intervention studies have been limited by size or design and have shown mixed results. The objective of this study was to determine the impact of a multifaceted, community-wide intervention on overall antibiotic use for young children and on use of broad-spectrum agents. In addition, we sought to compare the intervention's impact on commercially and Medicaid-insured children. We conducted a controlled, community-level, cluster-randomized trial in 16 nonoverlapping Massachusetts communities, studied from 1998 to 2003. During 3 years, we implemented a physician behavior-change strategy that included guideline dissemination, small-group education, frequent updates and educational materials, and prescribing feedback. Parents received educational materials by mail and in primary care practices, pharmacies, and child care settings. Using health-plan data, we measured changes in antibiotics dispensed per person-year of observation among children who were aged 3 to <72 months, resided in study communities, and were insured by a participating commercial health plan or Medicaid. The data include 223,135 person-years of observation. Antibiotic-use rates at baseline were 2.8, 1.7, and 1.4 antibiotics per person-year among those aged 3 to <24, 24 to <48, and 48 to <72 months, respectively. We observed a substantial downward trend in antibiotic prescribing, even in the absence of intervention. The intervention had no additional effect among children aged 3 to <24 months but was responsible for a 4.2% decrease among those aged 24 to <48 months and a 6.7% decrease among those aged 48 to <72 months. The intervention effect was greater among Medicaid-insured children and for broad-spectrum agents. A sustained, multifaceted, community-level intervention was only modestly successful at decreasing overall antibiotic use beyond substantial secular trends. The more robust impact among Medicaid-insured children and for specific medication classes provides an argument for specific targeting of resources for patient and physician behavior change.

Highlights

  • The more robust impact among Medicaid-insured children and for specific medication classes provides an argument for specific targeting of resources for patient and physician behavior change

  • Dr Finkelstein had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis; Drs Finkelstein, Huang, and Kleinman drafted the manuscript; Dr Kleinman and Ms Rifas-Shiman were responsible for statistical analysis; Drs Kleinman, Huang, Stille, Steingard, Soumerai, Ross-Degnan, Goldmann, and Platt, Ms RifasShiman, Mr Daniel, and Ms Schiff critically reviewed the manuscript; Drs Finkelstein, Kleinman, Soumerai, Ross-Degnan, Stille, Goldmann, and Platt and Mr Daniel were responsible for study concept and design; Drs Finkelstein, Huang, Platt, and Steingard, Mr Daniel, and Ms Schiff acquired the data; and Drs Finkelstein, Huang, Kleinman, Stille, Steingard, Soumerai, Ross-Degnan, Goldmann, and Platt, Ms Rifas-Shiman, and Ms Schiff were responsible for analysis and interpretation of data

  • Antibiotic resistance continues to be a threat to public health,[41,42] with high rates of human antibiotic use likely to be a substantial contributor.[10,11]

Read more

Summary

Objectives

Among children, continues to be a public health priority. Previous intervention studies have been limited by size or design and have shown mixed results. The objective of this study was to determine the impact of a multifaceted, community-wide intervention on overall antibiotic use for young children and on use of broad-spectrum agents. We sought to compare the intervention’s impact on commercially and Medicaidinsured children

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.